Genetic variations in cell-cycle pathway and the risk of oral premalignant lesions

Cancer

Volumn 113, Issue 9, 2008, Pages 2488-2495

  Ye, Yuanqing ^a   Lippman, Scott M ^a   Lee, J Jack ^a   Chen, Meng ^a,b   Frazier, Marsha L ^a   Spitz, Margaret R ^a   Wu, Xifeng ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell cycle pathway; Classification and regression tree analysis; Oral premalignant lesion; Single nucleotide polymorphisms

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RISK; CELL CYCLE REGULATION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE INTERACTION; GENETIC VARIABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LEUKOPLAKIA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING HABIT;

CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; CYCLIN D1; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; POLYMORPHISM, GENETIC; PRECANCEROUS CONDITIONS; RISK FACTORS; SMOKING;

EID: 55549106117     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.23854     Document Type: Article

References (25)

1. Mithani SK, Mydlarz WK, Grumbine FL, Smith IM, Califano JA. Molecular genetics of premalignant oral lesions. Oral Dis. 2007;13:126-133.
2. Lee JJ, Hong WK, Hittelman WN, et al. Predicting cancer development in oral leukoplakia: ten years of translational research. Clin Cancer Res. 2000;6:1702-1710.
3. Shafer WG, Waldron CA. Erythroplakia of the oral cavity. Cancer. 1975;36:1021-1028.
4. Huang M, Spitz MR, Gu J, et al. Cyclin D1 gene polymorphism as a risk factor for oral premalignant lesions. Carcinogenesis. 2006;27:2034-2037.
5. Raju B, Mehrotra R, Oijordsbakken G, Al-Sharabi AK, Vasstrand EN, Ibrahim SO. Expression of p53, cyclin D1 and Ki-67 in pre-malignant and malignant oral lesions: association with clinicopathological parameters. Anticancer Res. 2005;25:4699-4706.
6. Rosin MP, Cheng X, Poh C, et al. Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia. Clin Cancer Res. 2000;6:357-362.
7. Wu X, Lippman SM, Lee JJ, et al. Chromosome instability in lymphocytes: a potential indicator of predisposition to oral premalignant lesions. Cancer Res. 2002;62:2813-2818.
8. Wu X, Gu J, Grossman HB, et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet. 2006;78:464-479.
9. Gu J, Zhao H, Dinney CP, et al. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer. Clin Cancer Res. 2005;11:1408-1415.
10. Han J, Colditz GA, Samson LD, Hunter DJ. Polymorphisms in DNA double-strand break repair genes and skin cancer risk. Cancer Res. 2004;64:3009-3013.
11. Kim J, Shin DM, El-Naggar A, et al. Chromosome polysomy and histological characteristics in oral premalignant lesions. Cancer Epidemiol Biomarkers Prev. 2001;10:319-325.
12. Collins K, Jacks T, Pavletich NP. The cell cycle and cancer. Proc Natl Acad Sci USA. 1997;94:2776-2778.
13. Sherr CJ. Cancer cell cycles. Science. 1996;274:1672-1677.
14. Shintani S, Mihara M, Nakahara Y, et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. Oral Oncol. 2002;38:235-243.
15. Schoelch ML, Regezi JA, Dekker NP, et al. Cell cycle proteins and the development of oral squamous cell carcinoma. Oral Oncol. 1999;35:333-342.
16. Wu X, Zhao H, Amos CI, et al. p53 Genotypes and haplotypes associated with lung cancer susceptibility and ethnicity. J Natl Cancer Inst. 2002;94:681-690.
17. Le Marchand L, Seifried A, Lum-Jones A, Donlon T, Wilkens LR. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer. JAMA. 2003;290:2843-2848.
18. Kang S, Kim JW, Park NH, Song YS, Kang SB, Lee HP. Cyclin D1 polymorphism and the risk of endometrial cancer. Gynecol Oncol. 2005;97:431-435.
19. Rydzanicz M, Golusinski P, Mielcarek-Kuchta D, Golusinski W, Szyfter K. Cyclin D1 gene (CCND1) polymorphism and the risk of squamous cell carcinoma of the larynx. Eur Arch Otorhinolaryngol. 2006;263:43-48.
20. Huang WS, Tang R, Lin PY, et al. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan. Dis Colon Rectum. 2006;49:602-608.
21. Knudsen KE, Diehl JA, Haiman CA, Knudsen ES. Cyclin D1: polymorphism, aberrant splicing and cancer risk. Oncogene. 2006;25:1620-1628.
22. Zhang H, Bonney G. Use of classification trees for association studies. Genet Epidemiol. 2000;19:323-332.
23. Ch'ng S, Sullivan M, Yuan L, Davis P, Tan ST. Mast cells dysregulate apoptotic and cell cycle genes in mucosal squamous cell carcinoma. Cancer Cell Int. 2006;6:28.
24. Clurman BE, Porter P. New insights into the tumor suppression function of P27(kip1). Proc Natl Acad Sci USA. 1998;95:15158-15160.
25. Gonzalez P, Diez-Juan A, Coto E, et al. A single-nucleotide polymorphism in the human p27kip1 gene (-838C>A) affects basal promoter activity and the risk of myocardial infarction. BMC Biol. 2004;2:5.